CR

Cancer Research Communications

Cancer Research Communications is an AACR journal covering cancer research across molecular and cellular biology, tumor biology, immuno-oncology, emerging technologies and data science, therapeutic research and development, precision medicine and biomarkers, clinical research and trials, epidemiology and prevention, and health disparities and outcomes research. The journal publishes research articles and highlights monthly Editors' Picks.

Looking to publish in Cancer Research Communications? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 3.3
Quartile Q2
Open Access Type Open
eISSN 2767-9764
Invitation Only No
Cost Range Both submission and publication fees may be assessed; active AACR members in good standing receive waivers and discounts on selected fees, and additional discounts are available for many other authors.

Submission Instructions

Cancer Research Communications accepts the following article types. Click on an article type to view submission instructions.

Original Research

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. The abstract should be unstructured.
Manuscript Manuscript must be arranged as title page, text and references, tables, figure legends, and figures, and it must include Materials and Methods, Results, Discussion, Acknowledgments, and a Data Availability subsection at the end of Materials and Methods or Methods. The title page must include a running title of no more than 60 characters, the corresponding author’s full contact information, and the manuscript word count plus total number of figures and tables, and Original Research using custom computer code must include a Code Availability Statement explaining access and reuse and any limitations.
References References must be numbered and cited in the text by number in order of first mention. List all authors when there are 6 or fewer, list the first 6 followed by "et al." when there are more than 6, and ensure every reference is cited in the text.
Figures & Tables For initial submission, figures should appear with their legends together either embedded near the callout or on the same page at the end of the manuscript, supplementary files must be uploaded separately, and the manuscript order must place tables before figure legends and figures. Each table must have a descriptive title and each figure must have a legend with a short title sentence and description, with multi-panel figures labeled and described and all figures and tables cited in sequential order.
Reformat to Cancer Research Communications using Livewrite Premium

Recent Publications

p97 Inhibition Synergistically Enhances Hypomethylating Therapy Through Targeting of PLK1 in Acute Myeloid Leukemia

Steffan T. Nawrocki, Ning Wang, Claudia M. Espitia, Harley Wu, Claudia Villa Celi, Julian Olea, Paniz Zarand, Homa Dadrastoussi, Hittu Matta, Sruthi Sureshkumar, Madison E. Gamble, Natalie L. Hakim, David Drum, Jack Angeles, Kaijin Wu, Jiang F. Zhong, Xuelian Chen, Alex Duong, Jennifer S. Carew, Kevin R. Kelly

10.1158/2767-9764.crc-26-0035
View Publication

Ldha Regulates Osteosarcoma Lung Metastasis through Hedgehog Signaling

Rie Maki, Shingo Komura, Akihito Nagano, Ayumi Niwa, Hiroyuki Tomita, Yuuki Imai, Haruhiko Akiyama

10.1158/2767-9764.crc-25-0163
View Publication

CAR T-Cell Kinetics, Persistence and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-Cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study

Claire Roddie, William Day, Meera Raymond, Deborah Cluxton, Jason Caulfield, Heather Dainton-Smith, Brooke McElwee, Yanqing Hu, Karamjeet S. Sandhu, Eleni Tholouli, Aaron C. Logan, Paul Shaughnessy, Deborah Yallop, Pere Barba, Manuel Guerreiro, Jean A. Yared, Katharine Hodby, Bijal D. Shah, Wolfram Brugger, Pierre Lao-Sirieix, Michael R. Bishop, Daniel J. DeAngelo, Elias Jabbour, Jae H. Park

10.1158/2767-9764.crc-25-0756
View Publication

Multiple Myeloma Screening Education: A Community-Based Health Literacy Intervention

Karie Feldman, Hong Li, Diana Basali, Faiz Anwer, Kimberly Bell, Beth Faiman, Raymond D. Jackson, Sandra Mazzoni, Kayona Moore, Natasha Patel, Shahzad Raza, Jason Valent, Heather McKee. Hurwitz

10.1158/2767-9764.crc-26-0056
View Publication

Additivity, not synergy, underlies the efficacy of current combination regimens in urothelial cancer

Noah M. Schlachter, Eric J. Miller, Jonathan F. Anker, Matthew D. Galsky, Adam C. Palmer

10.1158/2767-9764.crc-26-0157
View Publication

Frequently asked questions

How long does it take to publish?

What are the publication costs?

Both submission and publication fees may be assessed; active AACR members in good standing receive waivers and discounts on selected fees, and additional discounts are available for many other authors.

Reformat to Cancer Research Communications using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Immune cells in cancer Cancer Genomics and Diagnostics CAR-T cell therapy research Cancer Cells and Metastasis Immunotherapy and Immune Responses Ferroptosis and cancer prognosis PARP inhibition in cancer therapy Lung Cancer Research Studies Prostate Cancer Treatment and Research Single-cell and spatial transcriptomics Epigenetics and DNA Methylation Cancer-related Molecular Pathways Lung Cancer Treatments and Mutations Cancer, Hypoxia, and Metabolism HER2/EGFR in Cancer Research Protein Degradation and Inhibitors Glioma Diagnosis and Treatment Sarcoma Diagnosis and Treatment Acute Myeloid Leukemia Research PI3K/AKT/mTOR signaling in cancer Immune Cell Function and Interaction Ubiquitin and proteasome pathways Melanoma and MAPK Pathways Cancer Research and Treatments

Related Journals

EJ
European Journal of Cancer Elsevier BV
FI
Frontiers in Oncology Frontiers Media
JO
JCO Oncology Practice LIPPINCOTT WILLIAMS & WILKINS
CN
Cancer Nanotechnology BioMed Central
Ne
Neoplasia Elsevier BV
RO
Radiation Oncology BioMed Central